Paul Prather Institution Verified
Sourced from institutional research profiles (UAMS TRI or ARA).
Professor
University of Arkansas for Medical Sciences
faculty
Pharmacology & Toxicology, College of Medicine
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Paul Prather serves as a Professor in the Department of Pharmacology & Toxicology at the University of Arkansas for Medical Sciences College of Medicine. His research program has focused on systems pharmacology and toxicology, as evidenced by his principal investigator roles on two federal grants from the NIH/National Institute of General Medical Sciences, totaling over $343,000. These grants support training initiatives, specifically the "Systems Pharmacology and Toxicology Training Program" and "Training in Systems Pharmacology and Toxicology (T-SPaT).
Prather's work in these areas involves understanding complex biological systems and how they respond to pharmacological agents and toxicants. The training programs he leads are designed to equip the next generation of researchers with the skills necessary to investigate these intricate interactions. He maintains an active laboratory website to share information about his research and the activities of his group. His contributions are recognized through his designation as a federal grant principal investigator, highlighting his success in securing external funding for research and education.
Federal Grants 2 $343,205 total
Grants & Funding
- Selective CB2 Cannabinoid Agonists as Candidate Therapeutics for Amyotrophic Lateral Sclerosis (ALS) ALS Association Principal Investigator
- Selective CB2 Cannabinoid Agonists as Candidate Therapeutics for ALS NIH Principal Investigator
- ABI P. Prather NIH T32 FY26 Y3 State of Arkansas Principal Investigator
- Systems Pharmacology and Toxicology Training Program NIH Principal Investigator
- OPIOID CONTROL MECHANISMS OF SIGNAL TRANSDUCTION NIH Principal Investigator
- CANNABINOID AGONIST REGULATION OF SIGNAL TRANSDUCTION NIH Principal Investigator
- Synthetic Cannabinoid Toxicity: Role of Biotransformation NIH Principal Investigator
- Use of precision deuteration to determine the contribution of norbuprenorphine to buprenorphine-associated neonatal abstinence syndrome NIH Co-Investigator
Frequent Collaborators
Similar Researchers
Based on overlapping research topics